Appropriate administration of yellow fever (YF) or Japanese encephalitis (JE) vaccines to
travelers requires an assessment of the traveler's risk for infection with these vector-borne …

The live, attenuated yellow fever (YF) 17D vaccine provides highly effective and durable
immunity and is widely used for travelers to and residents of endemic areas of South …

Background Yellow fever (YF) vaccine is considered safe; however, severe illness and
death following vaccination have been reported. Methods Vaccine Safety Datalink (VSD) …

Background: Yellow fever (YF) vaccines have been available since the 1930s and are
generally considered safe and effective. However, rare reports of serious adverse events …

Since 1996, the scientific community has become aware of 14 reports of yellow fever
vaccine (YEL)-associated viscerotropic disease (YEL-AVD) cases and four reports of YEL …

On February 26, 2015, the Advisory Committee on Immunization Practices (ACIP) voted that
a single primary dose of yellow fever vaccine provides long-lasting protection and is …

Yellow fever (YF) vaccine has been used for prevention of YF since 1937 with over 500
million doses administered. However, rare reports of severe adverse events following …

Yellow fever (YF), can be prevented by an attenuated vaccine (YEL). We reviewed
neurologic adverse events (AE) following YEL that were reported to the national Vaccine …

Yellow fever vaccine was considered one of the safest vaccines, but in recent years it was
found that it could rarely cause invasive and disseminated disease in some otherwise …

The yellow fever vaccine plays an essential role in protecting humans from yellow fever, and
millions of doses are administered each year. The attenuated live-virus vaccine has long …